GNOM Stock Overview
Gnomestar Craft Inc. engages in the production and distribution of cannabis product for medical and recreational use in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Gnomestar Craft Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.035 |
| 52 Week Low | CA$0.005 |
| Beta | 1.87 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -71.43% |
| 3 Year Change | -77.78% |
| 5 Year Change | -98.57% |
| Change since IPO | -98.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| GNOM | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -8.9% | -1.5% |
| 1Y | -71.4% | 49.0% | 4.7% |
Return vs Industry: GNOM underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: GNOM underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| GNOM volatility | |
|---|---|
| GNOM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 14.3% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: GNOM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine GNOM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Mark Lotz | gnomestarcannabis.com |
Gnomestar Craft Inc. engages in the production and distribution of cannabis product for medical and recreational use in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.
Gnomestar Craft Inc. Fundamentals Summary
| GNOM fundamental statistics | |
|---|---|
| Market cap | CA$854.11k |
| Earnings (TTM) | -CA$729.25k |
| Revenue (TTM) | CA$128.77k |
6.6x
P/S Ratio-1.2x
P/E RatioIs GNOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GNOM income statement (TTM) | |
|---|---|
| Revenue | CA$128.77k |
| Cost of Revenue | CA$795.95k |
| Gross Profit | -CA$667.18k |
| Other Expenses | CA$62.07k |
| Earnings | -CA$729.25k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0085 |
| Gross Margin | -518.12% |
| Net Profit Margin | -566.32% |
| Debt/Equity Ratio | -2.8% |
How did GNOM perform over the long term?
See historical performance and comparison